Sarbari Acharya
Molecular Biology · 2010–2011
A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 31 citations into it
- Biomaterials — 27 citations into it
- Biomedical Engineering — 21 citations into it
Whom Sarbari Acharya trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Sarbari Acharya's perspective
Ordered by how strongly the researchers Sarbari Acharya trusts endorse each paper. Same corpus, a different order for every researcher.
- TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors (Proceedings of the National Academy of Sciences of the United States of America)
- The endocytic pathway: a mosaic of domains (Nature reviews. Molecular cell biology)
- Nanomedicine: current status and future prospects (The FASEB Journal)
- Drug Delivery Systems: Entering the Mainstream (Science)
- Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. (Progress in lipid research)
- Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
- Effect of pegylation on pharmaceuticals (Nature reviews. Drug discovery)
- Nanocrystal targeting in vivo (Proceedings of the National Academy of Sciences of the United States of America)
- Molecular targets of dietary agents for prevention and therapy of cancer. (Biochemical Pharmacology)
- The dawning era of polymer therapeutics (Nature reviews. Drug discovery)
Their papers
- PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. (2011) — 1,049 citations
- Cancer nanotechnology: application of nanotechnology in cancer therapy. (2010) — 659 citations